NewEdge Advisors’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $429K | Buy |
15,540
+3,965
| +34% | +$109K | ﹤0.01% | 1788 |
|
|
2025
Q1 | $328K | Buy |
11,575
+10,185
| +733% | +$289K | ﹤0.01% | 1836 |
|
|
2024
Q4 | $57.8K | Sell |
1,390
-246
| -15% | -$10.2K | ﹤0.01% | 2473 |
|
|
2024
Q3 | $109K | Sell |
1,636
-6,137
| -79% | -$410K | ﹤0.01% | 2166 |
|
|
2024
Q2 | $923K | Sell |
7,773
-5,773
| -43% | -$686K | 0.01% | 1110 |
|
|
2024
Q1 | $1.44M | Buy |
13,546
+1,228
| +10% | +$131K | 0.01% | 820 |
|
|
2023
Q4 | $1.25M | Buy |
12,318
+6,172
| +100% | +$624K | 0.01% | 842 |
|
|
2023
Q3 | $635K | Sell |
6,146
-545
| -8% | -$56.3K | 0.01% | 1068 |
|
|
2023
Q2 | $813K | Sell |
6,691
-2,179
| -25% | -$265K | 0.01% | 960 |
|
|
2023
Q1 | $1.27M | Buy |
8,870
+576
| +7% | +$82.3K | 0.02% | 695 |
|
|
2022
Q4 | $1.04M | Buy |
8,294
+1,530
| +23% | +$191K | 0.03% | 497 |
|
|
2022
Q3 | $800K | Sell |
6,764
-1,237
| -15% | -$146K | 0.01% | 741 |
|
|
2022
Q2 | $1.14M | Buy |
+8,001
| New | +$1.14M | 0.02% | 621 |
|
|
2022
Q1 | – | Sell |
-8,724
| Closed | -$2.22M | – | 1441 |
|
|
2021
Q4 | $2.22M | Sell |
8,724
-4,234
| -33% | -$1.08M | 0.03% | 415 |
|
|
2021
Q3 | $4.99M | Buy |
12,958
+2,749
| +27% | +$1.06M | 0.12% | 171 |
|
|
2021
Q2 | $2.4M | Buy |
10,209
+7,889
| +340% | +$1.85M | 0.06% | 273 |
|
|
2021
Q1 | $304K | Sell |
2,320
-303
| -12% | -$39.7K | 0.01% | 806 |
|
|
2020
Q4 | $274K | Sell |
2,623
-3,980
| -60% | -$416K | 0.01% | 787 |
|
|
2020
Q3 | $467K | Buy |
+6,603
| New | +$467K | 0.02% | 595 |
|